SL STRATEGIES, LLC

Lobbying for BAVARIAN NORDIC · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2026 HHS Appropriations for Project BioShield Special Reserve Fund

Health Issues

Pandemic All Hazards Preparedness Act (PAHPA) reauthorization

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.